Company / Shareholders' Equity
ClearPoint Neuro, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$28.0M
FY2025
5-year range
$21.2M / $48.8M
FY2021-FY2025
Trend
+32.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$756,069 in FY2016 to $49M in FY2021.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +63.8%.
Improved from $21M to $28M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- +63.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +63.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 32.3% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.0M | +32.3% |
| FY2024 | $21.2M | +0.0% |
| FY2023 | $21.2M | -42.6% |
| FY2022 | $36.9M | -24.4% |
| FY2021 | $48.8M | +1952.5% |
| FY2020 | $2.4M | -48.2% |
| FY2019 | $4.6M | +203.7% |
| FY2018 | $1.5M | -74.1% |
| FY2017 | $5.8M | +870.9% |
| FY2016 | -$756.1K | +61.8% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026